Table II. Patients' cytogenetics.
# of pts | IDO-positive | IDO-negative | |
---|---|---|---|
Normal karyotype | 13 | 3 | 10* |
FLT3-ITD | 8 | 5 | 3 |
inv(16) | 5 | 5 | 0 |
MLL rearrangement | 5 | 5 | 0 |
t(8;21) | 5 | 1 | 4 |
p=0.0065 compared with children harboring inv(16) or MLL rearrangement.